Skip to main content
Top

Current Treatment Options in Oncology

Issue 7/2015

Content (6 Articles)

Lymphoma (JW Sweetenham, Section Editor)

Bone Marrow Transplantation for Peripheral T-Cell Non-Hodgkins’ Lymphoma in First Remission

Manish Sharma, Barbara Pro

Lymphoma (JW Sweetenham, Section Editor)

Follicular Lymphoma: First-Line Treatment Without Chemotherapy for Follicular Lymphoma

Patrick M. Reagan, Jonathan W. Friedberg

Lower Gastrointestinal Cancers (AB Benson, Section Editor)

Microsatellite Instability Testing and Its Role in the Management of Colorectal Cancer

Hisato Kawakami, Aziz Zaanan, Frank A. Sinicrope

Lower Gastrointestinal Cancers (AB Benson, Section Editor)

RAS Mutations Beyond KRAS Exon 2: A Review and Discussion of Clinical Trial Data

Timothy L. Cannon, Megan A. Kokon, Sara Shafqat, John F. Deeken

Breast Cancer (P Neven, Section Editor)

The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer

Kathleen Van Asten, An Poppe, Kevin Punie, Lynn Jongen, Anneleen Lintermans, Hans Wildiers, Patrick Neven

Upper Gastrointestinal Cancers (L Rajdev, Section Editor)

Management of Locally Advanced Adenocarcinoma of the Esophagus and Gastroesophageal Junction: Finally a Consensus

Lawrence Kleinberg, Malcolm Brock, Michael Gibson

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine